A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

PHASE3CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

November 17, 2011

Primary Completion Date

March 20, 2015

Study Completion Date

March 20, 2015

Conditions
Major Depressive Disorder
Interventions
DRUG

desvenlafaxine succinate sustained release

Subjects randomized to DVS SR group receive 25, 35 or 50 mg/day based on subject weight at the Baseline visit. DVS SR provided as oral tablets.

DRUG

fluoxetine

Subjects randomized to the fluoxetine group receive 20 mg/day. Fluoxetine provided as oral capsules

DRUG

placebo

Subjects randomized to the placebo group receive corresponding placebo tablets and/capsules

Trial Locations (43)

20852

Neuroscientific Insights, Rockville

30080

Institute for Behavioral Medicine, Smyrna

30331

Atlanta Center for Medical Research, Atlanta

32792

Winter Park Memorial Hospital, Winter Park

32801

Clinical Neuroscience Solutions, Inc., Orlando

33013

Amedica Research Institute, Incorporated, Hialeah

36303

Harmonex Neuroscience Research, Inc., Dothan

37000

Hospital Aranda de la Parra S.A. de C.V., León

38119

Clinical Neuroscience Solutions, Inc, Memphis

39232

Precise Research Centers, Flowood

44130

Nina F. Wimpie, MD Pediatrics, Middleburg Heights

North Star Medical Research, LLC, Middleburg Heights

45229

Cincinnati Children's Hospital Medical Center (New), Cincinnati

53227

Rogers Center For Research And Training, Milwaukee

63304

Midwest Research Group, Saint Charles

St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles

64610

CIT - Neuropsique, S.C., Monterrey

66211

Psychiatric Associates, Overland Park

68131

Creighton University, Omaha

69101

Heartland Pharma Developments, North Platte

70629

Lake Charles Clinical Trials,, Lake Charles

72211

Arkansas Psychiatric Clinic Clinical Research Trials, P.A., Little Rock

73103

IPS Research Company, Oklahoma City

73116

Cutting Edge Research Group, Oklahoma City

73118

Paradigm Research Professionals, LLC, Oklahoma City

76309

Grayline Clinical Drug Trials, Wichita Falls

78229

Focus & Balance, LLC, San Antonio

80045

Children's Hospital Colorado, Aurora

85395

Dedicated Clinical Research, Goodyear

85724

University of Arizona Clinical and Translational Science Center (CATS), Tucson

University of Arizona College of Medicine Dept of Psychiatry, Tucson

89128

Center for Psychiatry and Behavioral Medicine, Incorporated, Las Vegas

91206

Behavioral Research Specialists, LLC, Glendale

91950

Synergy Clinical Research Center, National City

92123

Sharp Mesa Vista Hospital, San Diego

92595

Elite Clinical Trials, Incorporated, Wildomar

92626

ATP Clinical Research, Inc. 1, Costa Mesa

92868

Neuropsychiatric Research Center of Orange County, Orange

Pacific Clinical Research Medical Group, Orange

97210

Summit Research Network (Oregon), Incorporated, Portland

98007

Northwest Clinical Research Center, Bellevue

98104

Summit Research Network (Seattle) LLC, Seattle

32789-3747

Kolin Research Group, Winter Park

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01372150 - A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD | Biotech Hunter | Biotech Hunter